| Filed On | Filing |
|---|---|
| 12 May 2021 |
Form 4/A: Crandall Robert L, Director
Bought 20,000 shares ($206K) |
| 16 Feb 2018 |
Form 4/A: Bayer Michael P., SVP, Controller & CAO
Received 800 shares by exercise or conversion · Gave up 248 shares to cover exercise price or tax ($3.15K) |
| 12 Jan 2018 |
Form 4/A: Williams Harris N, Director
Granted 3,477 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Townsend Charles C, Director
Granted 3,477 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Thorne Oakleigh, Director
Granted 3,477 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Payne Christopher D, Director
Granted 3,477 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Mundheim Robert H, Director
Granted 3,477 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Mayes Michele Coleman, Director
Granted 3,477 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Lemay Ronald T, Director
Granted 4,718 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Jones Hugh W, Director
Granted 3,477 Options (Right to Buy) |
| 12 Jan 2018 |
Form 4/A: Crandall Robert L, Director
Granted 3,477 Options (Right to Buy) |
| 26 Jan 2017 |
Form 4/A: Smagley Norman, EVP and CFO
Gave up 544 shares to cover exercise price or tax ($6.09K) · Acquired 175 shares (Other Transaction) ($1.96K) |
Loading...